Request Deal Involvement

Royalty Pharma and Pharmakon Advisors completed the $375m investment in Geron.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Cooley

legal advisors

Cooley

TD Cowen

financial advisors

TD Cowen

Goodwin Procter

legal advisors

Goodwin Procter

Fenwick & West

legal advisors

Fenwick & West

Akin Gump Strauss Hauer & Feld

legal advisors

Akin Gump Strauss Hauer & Feld

or

Principals

GERON CORPORATION

target

GERON CORPORATION

ROYALTY PHARMA

bidder

ROYALTY PHARMA

PHARMAKON ADVISORS

bidder

PHARMAKON ADVISORS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite